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Objective: To determine the influence of diabetes on the use of arterial reconstruction, the rate of amputation and death, 
and the quality of life of patients with severe limb ischaemia. 
Design: A prospective study of patients with the first episode of ischaemia. 
Setting: University tertiary referral centre. 
Methods: Thirty-seven patients with diabetes and 50 without diabetes, were studied over a 12 month period with complete 
follow-up. 
Main outcome measures: The proportion of patients undergoing an arterial reconstruction, amputation rate, death rate, 
and quality-of-life scores. 
Results: Patients with diabetes underwent an arterial reconstruction less often than patients without diabetes (7/37 vs. 
18/50). The odds of patients with diabetes having a higher incidence of adverse outcome was 1666:1 for minor amputation, 
26:1 for major amputation, and 4.7:1 for death. There was a tendency towards a lower quality of life for patients with 
diabetes at 3 (OR 1.94, p = 0.036), 6 (OR 1.58, p = 0.117), and 12 (OR 1.47, p = 0.185) months. 
Conclusions: In patients with diabetes, (1) the opportunity of undergoing an arterial reconstruction is lower, (2) morbidity 
and mortality are higher, and (3) the quality of life tends to be worse. 
Introduction 
Diabetes mellitus has been associated with a high 
incidence of adverse outcome in follow-up studies of 
12 patients with intermittent claudication.' Similar 
investigations of individuals with severe limb ischae- 
mia have been rare, 3'4 probably because a major 
amputation or an arterial reconstruction is often 
required. Although diabetes has also been associated 
with a worse prognosis after a major amputationff -7 
better or comparable patency rates for infrainguinal 
bypass grafts have been reported for patients with this 
8--12 disease. A possible xplanation for this unexpected 
finding may be that an arterial reconstruction is used 
less often or more selectively in this group of patients. 3 
Therefore, the possibility of a selection bias in surgical 
decision-making needs to be considered. To reduce 
bias of this type in studies on prognosis, it is necessary 
to adopt a prospective strateg~ to include individuals 
before the mode of treatment is selected, and to 
consider treatments other than arterial reconstruction. 
In such a stud3~ the outcome measures should include 
Please address all correspondence to: Maximiano Albers, MD Rua 
Ministro God6i, 1584, apt 74 ZIP 05015-001 Sao Paulo-Brazll. 
amputation and death rates but not graft patencies, 
since the latter are usable only in the subset of patients 
undergoing arterial reconstruction. In addition, an 
assessment of quality of life is also important when 
1 14 studying patients with either diabetes o, or arterial 
occlusive disease. 15'16 For these reasons, we decided to 
conduct his prospective study on severe limb ischae- 
mia with the principal aim of determining the influ- 
ence of diabetes mellitus on (1) the use of an arterial 
reconstruction, (2) the incidence of adverse outcome, 
and (3) the quality of life. 
Material and Methods 
Study design 
A cohort design was used to reduce selection bias, 
evaluate multiple outcomes, determine incidence 
rates, and assess the quality of life according to a 
standardised follow-up. The 12 month period of 
observation was considered adequate to achieve stable 
results in terms of limb salvage, rehabilitation, quality 
of life, and cost. 3-s' 16-18 The patients were recruited 
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consecutively from both the Outpatient Clinics and 
the Emergency Department of a public university 
hospital from January 2 to August 31, 1989. Zero time 
was the date of the first assessment of quality of life, 
before any treatment was selected. 
Inclusion criteria 
Based on the following criteria, 87 patients were 
admitted to the study: (1) age of 40 years or more, (2) 
palpable femoral but absent pedal pulses, (3) presence 
of rest pain, non-healing ulceration or gangrene, (4) no 
previous episode of severe ischaemia in either the 
affected or the contralateral limb, and (5) absence of 
cancer or mental disorders. 
Exposure and outcome variables 
The exposure variable was diabetes mellitus. A pre- 
vious diagnosis of diabetes was accepted unless 
evidence to the contrary was subsequently found. A 
fasting blood glucose level of 140 mg/100 ml or higher 
was also a criterion for the diagnosis. 
Minor and major amputation and death were the 
endpoints used in survival analysis. The proportion of 
patients undergoing an arterial reconstruction and the 
quality of life were also determined. 
Patients 
Fifty patients did not have diabetes mellitus (NDM 
group), while 37 did (DM group). Of the latter, 36 had 
type 2 diabetes and one had type 1 diabetes. The 
prevalence rate of 42% for diabetes was compatible 
with the findings of two other series at our institution, 
19 namelN 38% for 112 infrapopliteal bypasses and 40% 
2O for 167 major amputations. The high prevalence of 
diabetes in this study was probably a result of the 
referral pattern. On the other hang only 47 (20 DM, 27 
NDM) patients fulfilled the definition of critical leg 
ischaemiaY This corresponds to a prevalence rate of 
54% in each group, in agreement with a recently 
reported rate of 51%. 22 Also of importance, gender, 
history of smoking, hypertension, and contralateral 
disease were unequally distributed in both groups 
(Table 1). 
Table 1. Comparison of the cohorts at baseline 
With diabetes Without diabetes 
(n=37) (n=50) 
Age (years) 
Median 69 62 
Interquartile range 60-73 54-69 
Men 17 42 
Caucasians 30 42 
Smokers 14 40 
Hypertension 20 12 
Heart disease 23 22 
Cerebral ischaemia 10 9 
Rest pain only 2 8 
Infected lesion 20 21 
Critical ischaemia 20 27 
Contralateral disease 26 17 
Serum creatinine 13 8 
>1.4 mg/100 ml 
Initial treatment 
The initial treatment, hat adopted within 60 days of 
time zero, was classified as conservative, arterial 
reconstruction or major amputation. The first of these 
comprised non-surgical treatment: lumbar sympa- 
thectomy, debridement, peripheral nerve crushing, 
and toe or transmetatarsal amputation. Arterial recon- 
struction consisted of endarterectomy or bypass graft- 
ing in the affected limb, whereas major amputation 
was either below (BK), through (TK) or above (AK) the 
knee. 
Quality of life 
We selected the Spitzer's QL-INDEX 23 which includes 
five domains of quality of life: (1) Involvement in Own 
Occupation (Occupation), (2) Activities of The Daily 
Living (Daily Living), (3) Perception of Own Health 
~(Health), (4) Support of Family and Friends (Support), 
and (5) Outlook on Life (Outlook). The timeframe for 
this tool is the week previous to examination and each 
domain is scored zero, 1 or 2 so that the highest 
attainable score is 10. Although self-assessment has 
been recommended, 24-27 we did not use this method 
because of the limitations posed by old age, low 
literacy and either potential or actual visual loss. In 
addition, we also considered the advantages of using 
an interviewer (maximal response rate, no missin~ 
items, and minimal errors of misunderstanding)Y 
The first author (ACF) assessed all the 87 patients 
during 321 medical interviews in a 100% complete 
follow-up. Although not a blinded observer, this 
author was uninvolved in patient care. The last score 
of quality of life obtained before death was used at all 
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the subsequent points in time in which a reassessment 
had been planned, as described by Cox et al. 24 
(Strategy I). However, a second strategy was also 
adopted in which only the patients still alive were 
considered (Strategy II). 
Statistical analyses 
The use of an arterial reconstruction was analysed 
with standard methods for contingency tables. In the 
survival analysis, exponential survival models were 
considered using the prior-to-posterior Bayesian 
operation. 29'3° The posterior survival rates for the two 
groups were estimated. The probability that the DM 
group had a failure rate higher than that of the NDM 
group was evaluated. We represented these posterior 
probability values by pp-values and called the ratio 
pp/(1-pp) the Bayes factor. The prior distribution 
considered here is the uniform non-informative prior. 
The Mann-Whitney test and the generalised proce- 
dure of Morton and Dobson 31 were used for analysing 
the quality-of-life data. Partitioning of the QL-INDEX 
into its individual components was performed to 
show variations in each item. Stratification was under- 
taken to investigate the confounding effect of gender 
and history of smoking. Because of a strong associa- 
tion with both hypertension and contralateral disease, 
the confounding effect of these variables was probably 
partially corrected. Confidence intervals and p-values 
were used in the analyses of quality of life, although 
they have been omitted for convenience in some 
Tables. 
Resu l ts  
Use of an arterial reconstruction 
Thirty (13 DM, 17 NDM) patients received only 
Table 2. Survival analyses for l imb and life events 
conservative treatment while 25 (7 DM, 18 NDM) 
patients underwent an arterial reconstruction and the 
remaining 32 (17 DM, 15 NDM) had a major amputa- 
tion. Thus, the proportion of patients undergoing 
arterial reconstruction was 19% for DM and 36% for 
NDM. Although there was a trend towards lower 
reconstruction rates in diabetes, this was not statisti- 
caUy significant (Chi square = 2.25, d.f. = 1, 95% CI 4% 
to 34%, p = 0.133). 
Survival analyses for limb and life events 
There were 60 (29DM, 31 NDM) minor amputations, 
43 (21 DM, 22NDM) major amputations, and 13 (7 
DM, 6NDM) deaths, corresponding toa relative risk of 
2.32, 1.72, and 1.65, respectively. The probability that 
the failure rate was higher in the DM population of 
patients with severe limb ischaemia was pp > 0.9994 
for minor amputation, pp > 0.9634 for major amputa- 
tion, and pp >0.8235 for death. These results are 
shown in more detail in Table 2. 
Quality of life 
The quality of life at baseline was nearly the same in 
both the cohorts, with an OR of 0.93 (Table 3). With 
strategy I, the difference in favour of NDM patients 
was statistically significant at three months (OR) 1.94, 
p = 0.036), but not at 6 (OR 1.58, p = 0.117) or 12 (OR 
1.47, p = 0.185) months. With strategy II, the advantage 
of NDM patients was smaller and not significant 
(Table 3). 
The breakdown of the global scores of the QL- 
INDEX into the five primary domains yielded odds 
ratios higher than 1.00 (Table 4). A comparison of the 
12 month quality of life taking into account the 
ultimate state of the affected limb, showed an 
DM patients (n=37) 
Events X 
NDM patients (n=50) 
Events Y 
Bayes factor 
RR pp pp/(1-pp) 
A. Loss of the toes 29 3435 31 8506 2.32 0.9994 1665.667 
B. Loss of the foot 21 6115 22 10995 1.72 0.9634 26.322 
C. Death 7 11873 6 16780 1.65 0.8235 4.666 
DM patients (17 men, 20 women). 
NDM patients (42 men, 8 women). 
X and Y are the total of person-days. 
RR is the observed relative risk 
pp refers to the posterior p obability. 
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Table 3. Scores of quality of life at baseline and over a 12 month follow-up under two strategies 
Baseline 3 months 6 months 12 months 
Score Diabetes Yes No Yes No Yes No Yes No 
Deaths 0 0 3 (0) 3 (0) 4 (0) 4(0) 7(0) 6 (0) 
1 0 0 1 0 0 0 0 0 
2 4 9 3 (4) 5 5 (6) 2 1 (4) 2 
3 12 14 3 (4) 1 (2) 1 (2) 3 (5) 3 (4) 4 (6) 
4 13 13 13 (14) 13 (14) 9 (11) 10 (11) 8 (11) 8 (10) 
5 6 10 7 10 (11) 4 9 (10) 3 9 (10) 
6 2 3 6 10 5 4 3 5 
7 0 1 0 4 4 5 7 4 
8 0 0 0 2 3 6 5 6 
9 0 0 0 1 1 3 0 4 
10 0 0 1 1 1 4 0 2 (3) 
Strategy I 
Chi square 0.007 4.394 2.450 1.757 
p-value 0.933 0.036 0.117 0.185 
OR 0.97 1.94 1.58 1.47 
95% CI 0.47-1.98 1.04-3.60 0.89-2.80 0.83-2.60 
Strategy II 
Chi square 0.007 3.632 1.928 0.310 
p-value 0.933 0.057 0.16 0.58 
OR 0.97 1.87 1.53 1.19 
95% CI 0.47-1.98 0.98-3.56 0.84-2.79 0.64-2.19 
Values between parentheses are those used with strategy I. 
Table 4. Breakdown of the QL-INDEX into its five primary domains using scores obtained under strategy I 
Time 
(months) Baseline 3 months 6 months 12 months 
A. Occupation 
Diabetes 
Points 
OR 
B. Daily living 
Diabetes 
Points 
OR 
C. Health 
Diabetes 
Points 
OR 
D. Support 
Diabetes 
Points 
OR 
E. Outlook 
Diabetes 
Points 
OR 
Yes No Yes No Yes No Yes No 
0 31 43 31 36 28 31 29 33 
1 6 7 5 11 8 14 8 13 
2 0 0 1 3 1 5 0 4 
0.84 1.98 1.95 1.99 
Yes No Yes No Yes No Yes No 
0 21 25 20 19 18 18 17 18 
1 16 24 16 26 16 21 20 22 
2 0 1 1 5 3 11 0 10 
1.35 2.00 1.86 2.07 
Yes No Yes No Yes No Yes No 
0 16 17 7 6 6 4 6 3 
1 20 33 27 36 17 28 16 28 
2 1 0 3 8 14 18 15 19 
1.35 1.82 1.13 1.14 
Yes No Yes No Yes No Yes No 
0 1 1 2 0 2 0 2 0 
1 5 10 1 4 1 1 1 1 
2 31 39 34 46 34 49 34 49 
0.70 1.07 4.38 4.38 
Yes No Yes No Yes No Yes No 
0 10 17 8 5 7 4 7 5 
1 27 33 27 41 25 35 20 28 
2 0 0 2 4 5 11 10 17 
0.72 2.06 2.02 1.52 
None of the differences were statistically significant. 
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Table 5. Twelve-month quality of life according to the ultimate 
state of the limb 
No major BK or TK AK amputation 
amputation amputation 
Score Diabetes Yes No Yes No Yes No 
Deaths 6 3 0 2 1 1 
2 0(2) 0 0 2 2 0 
3 0 (1) 1 (2) 2 3 1 0 (1) 
4 1 (4) 1 3 4 (6) 4 3 
5 1 6 (7) 2 3 0 0 
6 2 3 1 2 0 0 
7 4 3 3 1 0 0 
8 5 6 0 0 0 0 
9 0 4 0 0 0 0 
10 0 2 (3) 0 0 0 0 
Strategy I 
Chi square 3.058 1.694 0.594 
p-value 0.080 0.193 0.441 
OR 2.01 0.47 2.75 
95% CI 0.92-4.39 0.15--1.46 0.21-36.02 
Strategy II 
Chi square 0.067 1.481 1.125 
p-value 0.796 0.223 0.289 
OR 1.13 0.49 - -  
95% CI 0.45-2.80 0.16-1.54 - -  
Values between parentheses are those used with strategy I. 
increased risk for DM persons in both the subgroup 
with no major amputat ion (19 DM; 29 NDM) and the 
subgroup with an AK amputat ion (7 DM, 4 NDM), but 
not in that with a BK amputat ion (11 DM, 17 NDM), as 
shown in Table 5. 
Stratification by gender and history of smoking 
revealed that the increased risk for both a minor 
amputat ion and a worse quality of life in DM patients 
was unconfounded. However, there were variations in 
risk in opposite directions for both major amputat ion 
and death (Table 6). 
Table 6. Stratified analysis of minor and major amputation, death, 
and quality of life 
Men Women 
Smoker Nonsmoker Smoker Nonsmoker 
A. Minor 1.61 2.77 5.23 1.87 
amputation 
B. Major 0.78 1.97 . .. 0.75 
amputation 
C. Death 3.37 3.96 ... 0.15 
D. Quality of life 
Baseline 0.85 1.00 0.83 1.71 
3 months 3.38 1.37 8.00 1.27 
6 months 1.20 2.13 7.40 2.50 
12 months 0.75 4.00 2.00 2.83 
Values are stratum-specific relative risks (A, B and C) or odds 
ratios (D). 
Discussion 
The results of this study indicate that DM patients 
undergo arterial reconstruction less often than NDM 
patients, with a difference of 17% and a relative 
decrease of 47%. An even greater difference of 29% 
(14% DM, 43% NDM) has been reported by others. 3
These differences are large enough to suggest that 
arterial reconstruction is considered with more care in 
DM patients than it is in NDM patients. If this is so, a 
selection bias is introduced in studies comparing the 
results of arterial reconstruction i these groups. For 
this reason, the possibility of a selection bias must  be 
seriously considered before accepting the better or 
comparable results for DM patients in some series of 
infrainguinal reconstruction. 8-12 Indeed, certain 
sources of bias in these studies are readily a~parent as 
is the case for demographic variables, 1 surgical 
indication, 12 type of bypass, 9"~° and distal anastomosis 
sites, s'1°-12 Other problems include confounding by 
the use of tobacco 1° and undue confidence in sub- 
group analysis, s'l° 
Under the Bayesian rationale, we believe that the 
probabil ity of a minor amputat ion i  the population of 
DM patients far exceeds that of the NDM population 
(Bayes factor 1666:1). Such a striking difference 
between DM and NDM patients would hardly be a 
result of confounding, as confirmed by a stratum- 
specific odds ratio ranging from 1.61 to 5.23 (Table 6). 
The difference was less impressive for a major 
amputat ion (Bayes factor 26:1). Consistent with this 
interpretation, the relative risk was  lower than 
1.00 in two strata (Table 6). This is an indication of 
confounding. However, a worse prognosis for the l imb 
in DM patients has been widely reported. 1"3-7'32"33 
Although the present study was too short in 
duration to confidently assess death rates, we found a 
slightly increased risk for DM patients, as expected. 3'5 
Chance is the best explanation for the disparities 
found with stratification for this latter variable (Table 
6). 
The quality of life scores were higher for NDM 
patients in all three assessments made during the 
follow-up. The stratum-specific odds ratios greater 
than 1.00 in 11 out of 12 fol low-up measures indicate 
absence of confounding. Although difficult to ascer- 
tain on clinical grounds, some support ive vidence in 
favour of the relevance of the differences in quality of 
life was provided by the partitioning of the QL- 
INDEX scores. This showed that all the five domains 
were scored higher in NDM patients, with no change 
in opposite direction that could mislead the summed 
scores. 24 In our opinion, this result is an indication of 
the strengths of the QL-INDEX in the setting of l imb 
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ischaemia. With regard to the individual domains, the 
high number of patients scoring zero for occupation is 
in agreement with the idea that it should be replaced 
by Mobility in order to improve the QL-INDEX. 34'3s 
The insensitivity to change identified for Support 34 
was also confirmed. On the contrar~ the readily 
apparent improvement with time for Daily Living, 
Health and Outlook reflects a good sensitivity to 
change (Table 4). 
As expected, quality of life scores were the highest 
for patients who did not have a major amputation, 
intermediate for those with either a BK or a TK 
amputation, and lowest in the subgroup having an AK 
amputation. These differences are a further indication 
of the adequacy of the QL-INDEX as an outcome 
measure in this study. Although a better quality of life 
was found for DM patients with a BK or a TK 
amputation, this was probably a result of small 
subgroup sizes. 
The probabilities under the rationale of Bayesian 
inference support our believe that adverse outcomes 
are more frequent in DM patients. In addition, the 
difference in quality of life according to the usual 
frequentist principles was also less favourable to 
these patients. Our conclusions are that in DM 
patients: (1) the opportunity of undergoing an arterial 
reconstruction is lower, (2) morbidity and mortality 
are higher, and (3) the quality of life tends to be 
worse. 
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